Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function

The irreversible Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has shown efficacy against B-cell tumors such as chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma. Fcγ receptors (FcγR) on immune cells such as macrophages play an important role in tumor-specific antibody-mediated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biol Chem
Main Authors: Ren, Li, Campbell, Amanda, Fang, Huiqing, Gautam, Shalini, Elavazhagan, Saranya, Fatehchand, Kavin, Mehta, Payal, Stiff, Andrew, Reader, Brenda F., Mo, Xiaokui, Byrd, John C., Carson, William E., Butchar, Jonathan P., Tridandapani, Susheela
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2016
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742765/
https://ncbi.nlm.nih.gov/pubmed/26627823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M115.687251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados